Evidence map›Paper›PMID 39881251›Full record

ArticleBMC public health2025

Assessment of out-of-pocket (OOP) expenditures on essential medicines for acute and chronic illness: a comparative study across regional and socioeconomic groups in India.

Ranjit Kumar Dehury, Imteyaz Ahmad, Manas Ranjan Behera, Janmejaya Samal, Varalakshmi Manchana, Jalal Mohammed, Parthsarathi Dehury, Deepanjali Behera, Nafisa Vaz E Desouza, Abhishek Dondapati

Abstract readComparative Study
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ranjit Kumar DehurySchool of Management Studies, University of Hyderabad, 500 046, Hyderabd, Telangana, India. ranjit@uohyd.ac.in.
Imteyaz AhmadSchool of Management Studies, University of Hyderabad, 500 046, Hyderabd, Telangana, India. iahmad@aiph.ac.in.
Manas Ranjan BeheraSchool of Public Health, Kalinga Institute of Industrial Technology (KIIT) Deemed to Be University, Bhubaneswar, 751024, India.
Janmejaya SamalSchool of Public Health, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.
Varalakshmi ManchanaSchool of Medical Sciences, University of Hyderabad, Hyderabad, Telangana, 500 046, India.
Jalal MohammedFaculty of Health, University of Canterbury, Christchurch, New Zealand.
Parthsarathi DehurySchool of Public Health, Asian Institute of Public Health University, Bhubaneswar, India.
Deepanjali BeheraSchool of Public Health, Kalinga Institute of Industrial Technology (KIIT) Deemed to Be University, Bhubaneswar, 751024, India.
Nafisa Vaz E DesouzaHealthcare Management Area, Goa Institute of Management, Panaji, Goa, India.
Abhishek DondapatiCentre for Healthcare Management, Administrative Staff College of India (ASCI), Hyderabad, India.

Funding

University of Hyderabad UoH/IoE/RC2/-21- 004
6 · The paper itself

Abstract

backgroundSubstantial out-of-pocket (OOP) expenditures push a large portion of the population below the poverty line, especially those residing in rural areas having low incomes. Individuals from economically disadvantaged states in India incur higher healthcare costs for hospitalization in public health centers than do those from more developed states. Economically poorer households in states such as Bihar and Odisha face significantly higher OOP expenditures for hospitalization in public health centers than do those in economically developed states such as Tamil Nadu.

objectiveThis study aims to compare households by using the wealth index and demographic factors concerning OOP expenditures on medicines for acute and chronic illnesses in Odisha, India. METHODOLOGY: A cross-sectional household survey was adopted to conduct the research. Access to medicines focused on OOP expenditures in Odisha is being studied by purposively selecting six districts: Rayagada, Kalahandi, Angul, Keonjhar, Khordha, and Kendrapara. A total of 902 households were surveyed. A stratified random sampling procedure was adopted to select the locations and households. The survey took place from October 2021 to February 2022. The sampled respondents were investigated for acute and chronic illnesses. The software SPSS version 25 was used to analyze the data. The details of the expenditures for the past four weeks were compared with those of medicines and healthcare expenses. Households were categorized into wealthy, middle, and poor classes. The prevalence of acute and chronic illnesses was analyzed in light of the share of medicine expenditures to total household expenditures.

resultsOut of 902 surveyed households, 173 (19.2%) spent out-of-pocket (OOP) money on medicines due to acute and chronic illnesses. Among the studied population, 23.7% were affected by acute illness, whereas 10.9% suffered from chronic illness. Wealthy households constituted most of the OOP expenditure (81 wealthy households), whereas 33 poor households also contributed to the OOP expenditure. According to the unadjusted odds ratio (UOR) analysis, wealthy households were 0.25 times less likely to spend more than 50% of their total monthly household budget on medicine than poor households (UOR = 0.25, 95% CI = 0.09-0.65). Similarly, ST households were 0.18 times less likely to spend more than 50% of their money on medicine from their budgets than SC households (UOR = 0.18, 95% CI = 0.04-0.72).

conclusionThe present study again reveals that capital regions (metropolitan regions) are well protected against OOP expenditures on medicines, but tribal areas are still underserved. The odds ratio reveals a critical positive association between high OOP and poor economic status in households in Odisha. That association must be minimized or nullified for equitable economic and social development.

Indexed as

Drugs, EssentialFinancing, PersonalHealth ExpendituresAcute DiseaseAdolescentAdultChronic DiseaseCross-Sectional StudiesFemaleHumansIndiaMaleMiddle AgedSocioeconomic FactorsYoung AdultDrugs, EssentialAcute illnessChronic illnessMedicine costOdishaOOP expenditureWealth index

Identifiers

PMID39881251
PMCPMC11780760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.